Chesapeake Urology Research Associates

Baltimore, Maryland 21327

0 studies enrolling now · 23 studies all time

What they study most

Advanced Prostate Cancer, Androgen Resistant Prostatic Cancer, Benign Prostate Hyperplasia, Bladder Cancer, Bladder Neoplasm, Cancer of the Prostate, Carcinoma in Situ, Cystitis, Interstitial, Erectile Dysfunction, Lower Urinary Tract Symptoms, Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-Sensitive Prostate Cancer

Studies at this site

• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer — Completed
• Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer — Running, not enrolling
• Acoustic Enhancer Research on Laser Lithotripsy (AEROLITH) — Completed
• Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b) — Completed
• Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a) — Completed
• Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) — Completed
• A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Stopped early
• Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent — Stopped early
• ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting — Stopped early
• Pivotal Study to Assess the Safety and Effectiveness of the iTind Device — Completed
• Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy — Completed
• The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma — Completed
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
• A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions — Completed
• An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms — Completed
• A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome — Completed
• Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer — Completed
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612) — Completed
• Study of AA4500 in the Treatment of Peyronie's Disease — Completed
• Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer — Stopped early
• Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer — Completed
• A Study of Degarelix in Patients With Prostate Cancer — Completed